Your browser doesn't support javascript.
loading
Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies.
Wang, Kui; Kievit, Forrest M; Zhang, Miqin.
Affiliation
  • Wang K; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.
  • Kievit FM; Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA.
  • Zhang M; Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA; Department of Neurological Surgery, University of Washington, Seattle, WA 98195, USA. Electronic address: mzhang@u.washington.edu.
Pharmacol Res ; 114: 56-66, 2016 12.
Article in En | MEDLINE | ID: mdl-27771464
ABSTRACT
Compared to conventional treatments, gene therapy offers a variety of advantages for cancer treatment including high potency and specificity, low off-target toxicity, and delivery of multiple genes that concurrently target cancer tumorigenesis, recurrence, and drug resistance. In the past decades, gene therapy has undergone remarkable progress, and is now poised to become a first line therapy for cancer. Among various gene delivery systems, nanoparticles have attracted much attention because of their desirable characteristics including low toxicity profiles, well-controlled and high gene delivery efficiency, and multi-functionalities. This review provides an overview on gene therapeutics and gene delivery technologies, and highlight recent advances, challenges and insights into the design and the utility of nanoparticles in gene therapy for cancer treatment.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Genetic Therapy / Gene Transfer Techniques / Nanoparticles / Neoplasms Limits: Animals / Humans Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Genetic Therapy / Gene Transfer Techniques / Nanoparticles / Neoplasms Limits: Animals / Humans Language: En Year: 2016 Type: Article